In situ assay for identifying inhibitors of bacterial transglycosylase |
| |
Authors: | Branstrom A A Midha S Goldman R C |
| |
Institution: | Advanced Medicine, Inc., 8 Clarke Drive, 08512, Cranbury, NJ, USA. abranstrom@advmedicine.com |
| |
Abstract: | An in situ transglycosylase assay has been developed using endogenously synthesized lipid II. The assay involves the preferential synthesis and accumulation of lipid II in a reaction mixture containing the cell wall membrane material isolated from Escherichia coli, exogenously supplied UDP-MurNAc-pentapeptide, and radiolabeled UDP-GlcNAc. In the presence of Triton X-100, the radiolabeled product formed is almost exclusively lipid II, while the subsequent formation of peptidoglycan is inhibited. Removal of the detergent resulted in the synthesis of peptidoglycan (25% incorporation of radiolabeled material) from the accumulated lipid II. This reaction was inhibited by moenomycin, a known transglycosylase inhibitor. In addition, tunicamycin, which affects an earlier step of the pathway by inhibiting MraY, had no effect on the formation of peptidoglycan in this assay, as expected. Similarly, ampicillin and bacitracin did not inhibit the formation of peptidoglycan under the conditions established. |
| |
Keywords: | Transglycosylase Peptidoglycan Moenomycin Lipid II Cell wall |
本文献已被 PubMed 等数据库收录! |
|